サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629872

医薬品ブリスター包装の世界市場（2024年～2032年）

Global Pharma Blisters Packaging Market - 2024-2032

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
医薬品ブリスター包装の世界市場（2024年～2032年）
出版日: 2024年12月30日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の医薬品ブリスター包装市場は2024年に58億3,000万米ドルに達し、2032年には87億2,000万米ドルに達すると予測され、予測期間2024年のCAGRは4.7%で成長します。

医薬品ブリスター包装市場には、錠剤、カプセル剤、トローチ剤などの医薬品を1回分ずつ確実に保持するために設計された、あらかじめ成形されたプラスチック包装の使用が含まれます。この包装ソリューションは、空気、湿気、汚染に対する効果的なバリア保護を提供することで、医薬品の保存期間を延ばすために不可欠です。ブリスターパックは通常、熱成形プラスチックまたはアルミニウムで形成された空洞で構成され、多くの場合、板紙や箔などの裏打ち材で密封されています。

市場力学：

促進要因と抑制要因

包装技術の革新

包装技術の革新は、安全性の向上、患者の服薬アドヒアランスの改善、持続可能性の促進により、医薬品ブリスターパッケージング市場を大きく推進すると予想されます。最近の進歩は、薬剤の使用状況や有効期限を監視できるセンサーや追跡装置などのスマート技術の統合に重点を置いています。

もう一つの重要な技術革新は、持続可能な包装ソリューションの開発です。ドライモールドファイバー（DMF）や紙ベースのブリスターパックなど、環境に優しい代替素材が従来のプラスチック包装の代替品として台頭してきています。これらの素材はリサイクル可能で生分解性もあるため、医薬品に必要な保護品質を保ちながら環境問題に対処することができます。例えば、2024年7月、Aluflexpack社は新製品「4-Infinity Form」の開発を発表しました。製薬業界向けに特別に設計されたこのブリスターパックは、全体がラッカー塗装されたアルミニウムで構成されており、従来の多素材パッケージに代わる持続可能でリサイクル可能なパッケージを提供します。この4-Infinity Formソリューションは、医薬品包装分野における環境への影響に対する懸念の高まりに対応するものです。

デザインの進歩により、ブリスターパックは、特に高齢者のような弱い立場の人々にとって、より使いやすくなっています。小児用耐性機構や高齢者に優しい設計などの機能により、医薬品が安全でありながら利用しやすくなっています。例えば、シュライナーメディファーマは2024年11月、新型の小児耐性スマートブリスターウォレットを発売しました。この製品は、臨床試験のための安全でスマートなパッケージングソリューションを提供します。シュライナーメディファーマは臨床試験用に多種多様なスマートブリスターパックを提供しています。

カスタマイズ可能な投与量追跡ツールの導入により、患者は投薬スケジュールを容易に監視できるようになり、その結果、服薬アドヒアランスが向上し、健康アウトカムが改善します。全体として、これらの技術革新はブリスターパッケージの機能性と持続可能性を高めるだけでなく、製薬業界における患者中心のソリューションに対する需要の高まりにも合致しています。以上のような要因が医薬品ブリスター包装市場に貢献しています。

医療廃棄物の増加

医療廃棄物の増加率は、医薬品ブリスター包装市場の大きな抑制要因になると予想されます。これは環境問題への懸念と規制圧力の高まりによるものです。ブリスターパッケージは医薬品の保護や保存期間の延長に効果的である一方、主にプラスチックとアルミニウムで構成されているため、廃棄やリサイクルの取り組みが複雑になります。

ブリスターパックに使用される材料は複雑であるため、リサイクルは困難であり、その結果、かなりの量の廃棄物が埋立地や焼却炉で処理されることになります。これは環境悪化の一因となるだけでなく、医薬品包装の持続可能性に関する消費者や規制当局の懸念も招きます。企業は、廃棄物の削減と持続可能性の促進を目的とした進化する規制を遵守しながら、これらの問題に対処するために包装戦略を革新し、適応させる必要があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 包装技術の革新
    • 抑制要因
      • 医療廃棄物の増加率
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 特許分析
  • 規制分析
  • SWOT分析
  • アンメットニーズ

第6章 タイプ別

  • 熱成形可能なブリスターパック
  • フェイスシールブリスターパック
  • フルフェイスシールブリスターパック
  • クラムシェルブリスターパック
  • 冷間成形ブリスターパック
  • 小児耐性ブリスター包装
  • シングルシールブリスターカード
  • その他

第7章 材料別

  • PVC（ポリ塩化ビニル）
  • PVDC（ポリ塩化ビニリデン）
  • ポリクロロトリフルオロエチレン
  • アルミニウム-アルミニウム（Alu-Alu）
  • コールドフォームフォイル（CFF）
  • 紙・段ボール
  • その他

第8章 用途別

  • タブレット
  • カプセル
  • アンプル
  • 注射器
  • その他

第9章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ

第10章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第11章 企業プロファイル

  • ACG
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
  • KAA Timex LR
  • Amcor plc
  • Caprihans India Limited
  • Constantia Flexibles
  • Honeywell International Inc.
  • Sonoco Products Company
  • The Dow Chemical Company
  • Tekni-Plex, Inc.

第12章 付録

目次
Product Code: PH8900

The global pharma blisters packaging market reached US$ 5.83 billion in 2024 and is expected to reach US$ 8.72 billion by 2032, growing at a CAGR of 4.7% during the forecast period 2024-2032.

The pharmaceutical blister packaging market includes the usage of pre-formed plastic packaging designed to securely hold individual doses of medications, such as tablets, capsules, and lozenges. This packaging solution is essential for enhancing the shelf life of pharmaceuticals by providing effective barrier protection against air, moisture, and contamination. Blister packs typically consist of a cavity formed from thermoformed plastic or aluminum, often sealed with a backing material such as paperboard or foil.

Market Dynamics: Drivers & Restraints

Innovations in packaging technology

Innovations in packaging technology are expected to significantly propel the pharma blister packaging market by enhancing safety, improving patient adherence, and promoting sustainability. Recent advancements have focused on integrating smart technologies, such as sensors and tracking devices, which can monitor medication usage and expiration dates.

Another significant innovation is the development of sustainable packaging solutions. Eco-friendly alternatives like Dry Molded Fiber (DMF) and paper-based blister packs are emerging as viable substitutes for traditional plastic packaging. These materials are both recyclable and biodegradable, addressing environmental concerns while still providing the necessary protective qualities for pharmaceutical products. For instance, in July 2024, Aluflexpack announced the development of a new product, the 4-Infinity Form. This blister pack, designed specifically for the pharmaceutical industry, is constructed entirely of lacquered aluminum, offering a sustainable and recyclable alternative to traditional multi-material packaging. The 4-Infinity Form solution addresses growing concerns about the environmental impact within the pharmaceutical packaging sector.

Advancements in design are also making blister packs more user-friendly, particularly for vulnerable populations such as the elderly. Features like child-resistant mechanisms and senior-friendly designs ensure that medications remain safe yet accessible. For instance, in November 2024, Schreiner MediPharm launched a New Child-Resistant Smart Blister Wallet. The product provides secure and smart packaging solutions for clinical trials. Schreiner MediPharm offers a wide variety of smart blister packs for clinical trials.

The introduction of customizable dosage tracking tools allows patients to easily monitor their medication schedules, thereby enhancing adherence and improving health outcomes. Overall, these innovations not only enhance the functionality and sustainability of blister packaging but also align with the growing demand for patient-centric solutions in the pharmaceutical industry. Thus, the above factors are contributing to the pharma blisters packaging market.

Growing rate of medical waste

The increasing rate of medical waste is expected to be a significant restraining factor for the pharma blister packaging market. This is due to increasing environmental concerns and regulatory pressures. Blister packaging, while effective in protecting medications and extending shelf life, is primarily composed of plastic and aluminum, which complicates disposal and recycling efforts.

The complexity of materials used in blister packs makes them challenging to recycle, resulting in a considerable amount of waste that often ends up in landfills or incinerators. This not only contributes to environmental degradation but also raises concerns among consumers and regulatory bodies regarding the sustainability of pharmaceutical packaging practices. Companies will need to innovate and adapt their packaging strategies to address these issues while complying with evolving regulations aimed at reducing waste and promoting sustainability.

Segment Analysis

The global Pharma Blisters Packaging market is segmented based on disease type, drug class, route of administration, distribution channel, end-user, and region.

Type:

Thermoformable blister packs segment is expected to dominate the global pharma blisters packaging market share

The thermoformable blister packs segment is expected to dominate the pharmaceutical blister packaging market due to several compelling factors that enhance its appeal to manufacturers and end-users alike. Thermoformable technology utilizes heat and pressure to shape plastic sheets into precisely formed cavities, allowing for intricate designs that accommodate various pharmaceutical products, including tablets and capsules, without compromising their integrity during storage and transport.

Companies are introducing various packaging solutions that are thermoformable. For instance, in November 2023, Coveris manufactured a new recyclable, flexible thermoforming film solution, called Formpeel P, for use in various medical packaging applications. The rising product innovations also contribute to the segment's growth.

One of the key advantages of thermoforming is its cost-effectiveness. Compared to cold-forming technology, thermoforming has lower initial tooling and equipment costs, making it more accessible for manufacturers looking to optimize production without incurring substantial expenses.

Geographical Analysis

North America is expected to hold a significant position in the global pharma blisters packaging market share

The North America is expected to hold a significant position in the global pharma blisters packaging market. This is due to the rising innovation in packaging solutions, increasing pharmaceutical production and consumption. The presence of a large number of packaging companies is expected to contribute to the region's market growth.

The presence of major pharmaceutical companies, including giants like Pfizer and Moderna, further solidifies North America's position in the blister packaging market. These companies not only dominate the production of high-demand pharmaceuticals but also invest heavily in research and development, leading to a continuous influx of new drug formulations that require effective packaging solutions.

The increasing focus on patient safety and adherence to medication regimens further emphasizes the need for effective packaging that can protect pharmaceuticals from environmental factors. Moreover, advancements in packaging technology are enhancing the functionality of blister packs, making them more user-friendly and sustainable. For instance, in October 2022, US-based pharmaceutical provider TekniPlex Healthcare introduced the world's first fully transparent recyclable mid-barrier blister package at Pack Expo in Chicago.

Asia Pacific is growing at the fastest pace in the global pharma blisters packaging market

Asia-Pacific is currently experiencing the fastest growth in the pharma blister packaging market. This growth is driven by the rising consumption of pharmaceutical products due to the incidence of several chronic diseases particularly in China and India, increasing pharmaceutical production by manufacturing companies, and the increasing innovations in packaging solutions.

Competitive Landscape

The major global players in the pharma blisters packaging market include ACG, KAA Timex LR, Amcor plc, Caprihans India Limited, Constantia Flexibles, Honeywell International Inc., Sonoco Products Company, The Dow Chemical Company, Tekni-Plex, Inc. and Korber AG among others.

Key Developments

  • In April 2022, Huhtamaki introduced a first-to-market sustainable innovation for the global pharmaceutical and healthcare industry. Huhtamaki's Push Tab(R) blister lid is mono-material PET and free from aluminum.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Pharma Blisters Packaging market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Material
  • 3.3. Snippet by Application
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations in packaging technology
    • 4.1.2. Restraints
      • 4.1.2.1. Growing rate of medical waste
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. Regulatory Analysis
  • 5.6. SWOT Analysis
  • 5.7. Unmet Needs

6. By Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Thermoformable Blister Packs*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Face Seal Blister Packs
  • 6.4. Full-face Seal Blister Packs
  • 6.5. Clamshell Blister Packs
  • 6.6. Cold-formable Blister Packs
  • 6.7. Child-resistant Blister Packaging
  • 6.8. Single-seal Blister Cards
  • 6.9. Others

7. By Material

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 7.1.2. Market Attractiveness Index, By Material
  • 7.2. PVC (Polyvinyl Chloride) *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. PVDC (Polyvinylidene Chloride)
  • 7.4. Polychlorotrifluoroethylene
  • 7.5. Aluminum-Aluminum (Alu-Alu)
  • 7.6. Cold Form Foil (CFF)
  • 7.7. Paper & Cardboard
  • 7.8. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Tablets*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Capsules
  • 8.4. Ampoules
  • 8.5. Syringes
  • 8.6. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. ACG*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. KAA Timex LR
  • 11.3. Amcor plc
  • 11.4. Caprihans India Limited
  • 11.5. Constantia Flexibles
  • 11.6. Honeywell International Inc.
  • 11.7. Sonoco Products Company
  • 11.8. The Dow Chemical Company
  • 11.9. Tekni-Plex, Inc.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us